Birk Venture invests in Nordic Nanovector AS. Nordic Nanovector is a
privately held company established in 2009. The company develops
novel anticancer therapeutics based on The Norwegian Radium
Hospital and Nordic Nanovector’s own innovative research on tumor
targeted antibody based nanovector. With this investment Birk Venture
makes a new important engagement in the development of new
innovative medicines in cancer.
